OSLO, Norway, Feb. 20, 2025 /PRNewswire/ — In connection with the release of the results for the full year and fourth quarter 2024, Oncoinvent invites to the following events: Thursday 27 February 202507.30 CETRelease of […]
Tag: Oncoinvent AS
Oncoinvent Announces First Patient Dosed in its Phase 2 Clinical Trial of Radspherin® in Ovarian Cancer Patients
OSLO, Norway, Oct. 10, 2024 /PRNewswire/ — Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announced that the first patient has been dosed in its Phase 2 study of Radspherin® […]
